Try our beta test site
3 studies found for:    18378569 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Trial of DA-EPOCH Regimen for NHL With HLH
Condition: NHL With Hemophagocytic Lymphohistiocytosis
Intervention: Drug: DA-EPOCH
2 Not yet recruiting R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL
Condition: Lymphoma, Large B-Cell, Diffuse
Interventions: Drug: Rituximab;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Vindesine;   Drug: Bleomycin
3 Terminated Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Intervention: Drug: MK2206

Study has passed its completion date and status has not been verified in more than two years.